MoneyWorks4Me

Lupin submits board meeting intimation

25 Apr 2023 Evaluate
Lupin has informed that the meeting of the Board of Directors of the Company is scheduled on 09/05/2023, to consider and approve the audited financial results of the Company for the quarter and year ended March 31, 2023 and recommend dividend, if any.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..